These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3097356)

  • 1. [Effect of intratumor mitomycin-C injection on growth of homologously implanted pancreatic cancer in Syrian golden hamster].
    Moriai T; Takebe T; Ohyama K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Aug; 83(8):1515-9. PubMed ID: 3097356
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental study on multidisciplinary treatment of pancreatic cancer.
    Moriai T; Takeba T; Makino I
    Int J Pancreatol; 1990 Apr; 6(3):161-79. PubMed ID: 2118936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The morphologic and biologic patterns of chemically induced pancreatic adenocarcinoma in Syrian golden hamsters after homologous transplantation.
    Takahashi M; Runge R; Donnelly T; Pour P
    Cancer Lett; 1979 Jul; 7(2-3):127-33. PubMed ID: 476607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
    Chang BK; Gutman R
    Cancer Res; 1982 Jul; 42(7):2666-70. PubMed ID: 6805945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of combined use of CR 1505 with UFT on tumor growth of transplanted pancreatic cancer in the Syrian golden hamster: preliminary report].
    Tomioka M; Miyazaki N; Yamamoto M; Saito Y
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):106. PubMed ID: 1549090
    [No Abstract]   [Full Text] [Related]  

  • 6. [An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents].
    Omote Y
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1155-66. PubMed ID: 3141773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutics: mitomycin C: a brief review.
    Reich SD
    Cancer Nurs; 1982 Apr; 5(2):152-4. PubMed ID: 6804088
    [No Abstract]   [Full Text] [Related]  

  • 8. Accessible standardized intracutaneous implants: pancreatic adenocarcinoma in the Syrian hamster.
    LaMuraglia GM; Abu-Khalaf MM; Malt RA
    Br J Cancer; 1984 Aug; 50(2):235-7. PubMed ID: 6466541
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplantable ductal adenocarcinoma of the Syrian hamster pancreas.
    Scarpelli DG; Rao MS
    Cancer Res; 1979 Feb; 39(2 Pt 1):452-8. PubMed ID: 216489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic ductulitis in Syrian golden hamsters bearing homologous transplantable pancreatic adenocarcinomas.
    Runge R; Takahashi M; Pour P
    Cancer Lett; 1978 Oct; 5(4):225-9. PubMed ID: 688204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homologous transplantation of di-isopropanol nitrosamine induced pancreatic ductal adenocarcinoma in Syrian golden hamster (author's transl)].
    Oyama K; Sakai Y; Kagaya T; Saito T; Tatebe T
    Nihon Shokakibyo Gakkai Zasshi; 1981 Apr; 78(4):946. PubMed ID: 6268867
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes enhances growth of pancreatic carcinoma cells.
    Fisher WE; McCullough PJ; Ray MB; Rogers DH; Bell RH
    Surgery; 1988 Aug; 104(2):431-6. PubMed ID: 3400068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological characteristics of pancreatic carcinoma induced by N-nitrosobis (2-hydroxypropyl) amine in Syrian golden hamster].
    Ishikawa O; Wada A; Fukuda I; Matsui Y; Iwanaga T; Terasawa T
    Nihon Shokakibyo Gakkai Zasshi; 1982 Sep; 79(9):1771-7. PubMed ID: 7154369
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters.
    Egami H; Tomioka T; Tempero M; Kay D; Pour PM
    Am J Pathol; 1991 Mar; 138(3):557-61. PubMed ID: 2000935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HaP-T1 Syrian golden hamster pancreatic cancer model: cell implantation is better than tissue implantation.
    Abraham AT; Shah SR; Davidson BR
    Pancreas; 2004 Nov; 29(4):320-3. PubMed ID: 15502649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative resection of orthotopically implanted pancreatic cancer in Syrian golden hamsters.
    Morioka CY; Saito S; Kita K; Watanabe A
    Int J Pancreatol; 2000 Dec; 28(3):207-13. PubMed ID: 11373058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrically mediated drug delivery for treating subcutaneous and orthotopic pancreatic adenocarcinoma in a hamster model.
    Jaroszeski MJ; Illingworth P; Pottinger C; Hyacinthe M; Heller R
    Anticancer Res; 1999; 19(2A):989-94. PubMed ID: 10368643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a transplantable model of pancreatic duct adenocarcinoma.
    Townsend CM; Franklin RB; Gelder FB; Glass E; Thompson JC
    Surgery; 1982 Jul; 92(1):72-8. PubMed ID: 7089870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
    Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
    In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.